These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15472245)

  • 1. Merck withdraws arthritis drug worldwide.
    Singh D
    BMJ; 2004 Oct; 329(7470):816. PubMed ID: 15472245
    [No Abstract]   [Full Text] [Related]  

  • 2. The coxibs, selective inhibitors of cyclooxygenase-2.
    FitzGerald GA; Patrono C
    N Engl J Med; 2001 Aug; 345(6):433-42. PubMed ID: 11496855
    [No Abstract]   [Full Text] [Related]  

  • 3. Coxibs and cardiovascular disease.
    Fitzgerald GA
    N Engl J Med; 2004 Oct; 351(17):1709-11. PubMed ID: 15470192
    [No Abstract]   [Full Text] [Related]  

  • 4. Vioxx risk could signify trouble in class.
    Frantz S
    Nat Rev Drug Discov; 2004 Nov; 3(11):899-901. PubMed ID: 15558856
    [No Abstract]   [Full Text] [Related]  

  • 5. The coxibs, selective inhibitors of cyclooxygenase-2.
    Killen JP
    N Engl J Med; 2001 Dec; 345(23):1708; author reply 1709. PubMed ID: 11759656
    [No Abstract]   [Full Text] [Related]  

  • 6. [Selective COX-2 inhibitor. Stomach protection--but not always].
    MMW Fortschr Med; 2001 Jun; 143(25):60. PubMed ID: 11469005
    [No Abstract]   [Full Text] [Related]  

  • 7. [Specific COX-2 inhibitors. Also effective in arthritis?].
    Einecke D
    MMW Fortschr Med; 2000 Jan; 142(3):10. PubMed ID: 10726454
    [No Abstract]   [Full Text] [Related]  

  • 8. [A new pharmacological principle is effective--rofecoxib. Specific COX-2 inhibition].
    MMW Fortschr Med; 1999 Dec; 141(51-52):66-7. PubMed ID: 10949630
    [No Abstract]   [Full Text] [Related]  

  • 9. [No loss of effectiveness with rofecoxib. Long-term control of rheumatoid pain].
    Einecke D
    MMW Fortschr Med; 2002 Nov; 144(46):68. PubMed ID: 12534087
    [No Abstract]   [Full Text] [Related]  

  • 10. Anaphylactoid reaction to a cyclooxygenase-2 inhibitor in a patient who had a reaction to a cyclooxygenase-1 inhibitor.
    Schellenberg RR; Isserow SH
    N Engl J Med; 2001 Dec; 345(25):1856. PubMed ID: 11752370
    [No Abstract]   [Full Text] [Related]  

  • 11. MI risk prompts rofecoxib withdrawal.
    Thompson CA
    Am J Health Syst Pharm; 2004 Nov; 61(21):2234-6, 2238. PubMed ID: 15552625
    [No Abstract]   [Full Text] [Related]  

  • 12. COX-2 inhibitors: better than traditional NSAIDs? Vioxx and Celebrex may be no less risky than NSAIDs.
    Atkinson HG
    Health News; 2002 Aug; 8(8):5. PubMed ID: 12206146
    [No Abstract]   [Full Text] [Related]  

  • 13. Rofecoxib-induced renal dysfunction in a patient with compensated cirrhosis and heart failure.
    Ofran Y; Bursztyn M; Ackerman Z
    Am J Gastroenterol; 2001 Jun; 96(6):1941. PubMed ID: 11419859
    [No Abstract]   [Full Text] [Related]  

  • 14. [COX-2 inhibitor in arthrosis. Discontinuation before operations not necessary].
    MMW Fortschr Med; 2001 Oct; 143(42):64. PubMed ID: 11697296
    [No Abstract]   [Full Text] [Related]  

  • 15. Differences between COX-2-specific inhibitors: clinical and economic implications.
    Sonnenblick EH
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S428-30. PubMed ID: 12416792
    [No Abstract]   [Full Text] [Related]  

  • 16. [New study of selective COX-2 inhibitors. Protecting the stomach while risking the heart? (interview by Dr. Beate Schumacher)].
    Zeidler H
    MMW Fortschr Med; 2001 Sep; 143(35-36):14. PubMed ID: 11584521
    [No Abstract]   [Full Text] [Related]  

  • 17. Why do COX-2 inhibitors increase risk of cardiovascular events?
    Frankish H
    Lancet; 2002 Apr; 359(9315):1410. PubMed ID: 11978344
    [No Abstract]   [Full Text] [Related]  

  • 18. [COX-2 specific inhibitors: are NSAIDs and the stomach become reconcilied?].
    Bannwarth B
    Gastroenterol Clin Biol; 2001 Apr; 25(4 Suppl):B79-84. PubMed ID: 11449148
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute, anuric renal failure associated with two doses of a cyclooxygenase-2 inhibitor.
    Wahba AL; Soper C
    Nephron; 2001 Oct; 89(2):239. PubMed ID: 11549912
    [No Abstract]   [Full Text] [Related]  

  • 20. COX-2 inhibitors: new drugs for the management of pain and inflammation.
    Hutchins V; Hutchins B
    Dent Today; 2001 Feb; 20(2):56-61. PubMed ID: 12524847
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.